Eduardo Antonio Lara-Perez, Felix Guillermo Marquez-Celedonio and Cesar Virgen-Ortega
Director of Clinasma, Mexico Director of Research in Medicine, Colombia President college of pediatrics of tabasco, Mexico
Posters & Accepted Abstracts: Arch Med
Background: Bronchial asthma is a condition that affects up to 13% of the school population, is associated with reduced inspiratory and expiratory flows, rhinitis and respiratory infections. Ionic nasal saline solution is an adjuvant option for treatment with bactericidal and virucidal effects. Objective: To determine the effect of the use of ionized nasal saline in the Maximum Inspiratory Flow (MIF) and pPeak Expiratory Flow (PEF) and the frequency of respiratory infections in school children with bronchial asthma. Material & Methods: Pre-experimental study with baseline demographic, anthropometric measurements, frequency of respiratory infections and inspiratory and expiratory flows. Follow-up for four months with monthly evaluations of mif, pef and presence of respiratory infections. Inferential analysis with: chi square, mann-whitney, wilcoxon and student's t. Results: We included 80 schoolchildren of 8.7±2.1 years, height of 1.31±2.1 m, 48 (60.0%) of male and 32 female (40%). The MIF evolved from 58.4±19.3 l/sec initial and 104.7±29.2 at four months (p<0.05), PEF initiation 192.7±58.7 to 222.3±67.0 final (p<0.05) respiratory infections 100% to 88.8% first month and 0.0% at the end (p<0.05). Conclusions: The administration of ionized nasal saline solution in asthmatic school children allows to recover values of MIF and PEF and to reduce the frequency of infectious airways, independently of the sex and category of acute or chronic infection.
E-mail:
lape5104@hotmail.com
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
